194 related articles for article (PubMed ID: 21197202)
1. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
Can Vet J; 2010 Oct; 51(10):1109-14. PubMed ID: 21197202
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor in canine cutaneous fibrosarcomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
J Comp Pathol; 2009 Nov; 141(4):229-36. PubMed ID: 19560781
[TBL] [Abstract][Full Text] [Related]
4. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor in canine mammary tumors.
Restucci B; Papparella S; Maiolino P; De Vico G
Vet Pathol; 2002 Jul; 39(4):488-93. PubMed ID: 12126152
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic markers in canine lymphoma tissues do not predict survival times in chemotherapy treated dogs.
Wolfesberger B; Tonar Z; Fuchs-Baumgartinger A; Walter I; Skalicky M; Witter K; Thalhammer JG; Pagitz M; Kleiter M
Res Vet Sci; 2012 Jun; 92(3):444-50. PubMed ID: 21596405
[TBL] [Abstract][Full Text] [Related]
7. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
[TBL] [Abstract][Full Text] [Related]
8. VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study.
Santos A; Lopes C; Gärtner F; Matos AJ
Vet Comp Oncol; 2016 Sep; 14(3):e83-92. PubMed ID: 24976305
[TBL] [Abstract][Full Text] [Related]
9. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of vascular endothelial growth factor-A (VEGF-A) and its receptor in canine prostate cancer.
Leis-Filho AF; Lainetti PD; Kobayashi PE; Palmieri C; Amorim RL; Fonseca-Alves CE
Prostate; 2021 Oct; 81(14):1021-1031. PubMed ID: 34320239
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor receptor Flk-1 in canine mammary tumours.
Restucci B; Borzacchiello G; Maiolino P; Martano M; Paciello O; Papparella S
J Comp Pathol; 2004; 130(2-3):99-104. PubMed ID: 15003465
[TBL] [Abstract][Full Text] [Related]
12. Mast cells in canine cutaneous hemangioma, hemangiosarcoma and mammary tumors.
Woldemeskel M; Rajeev S
Vet Res Commun; 2010 Feb; 34(2):153-60. PubMed ID: 20127412
[TBL] [Abstract][Full Text] [Related]
13. Expression of hypoxia-inducible factor-1α and vascular density in mammary adenomas and adenocarcinomas in bitches.
Madej JA; Madej JP; Dziegiel P; Pula B; Nowak M
Acta Vet Scand; 2013 Oct; 55(1):73. PubMed ID: 24153191
[TBL] [Abstract][Full Text] [Related]
14. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.
Carvalho MI; Pires I; Prada J; Raposo TP; Gregório H; Lobo L; Queiroga FL
Vet Comp Oncol; 2017 Jun; 15(2):619-631. PubMed ID: 26792550
[TBL] [Abstract][Full Text] [Related]
15. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
16. Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis.
Król M; Pawłowski KM; Dolka I; Musielak O; Majchrzak K; Mucha J; Motyl T
Vet Res Commun; 2011 Oct; 35(7):409-23. PubMed ID: 21713436
[TBL] [Abstract][Full Text] [Related]
17. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours.
Raposo TP; Pires I; Carvalho MI; Prada J; Argyle DJ; Queiroga FL
Vet Comp Oncol; 2015 Dec; 13(4):464-74. PubMed ID: 24119241
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
